What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year.| Amy Feldman
For years, Jake Becraft has been working at the bleeding edge of cancer research. Now, with solid early clinical results and a boatload of cash he’s hoping to bring his first innovative therapeutic to market by 2030.| Amy Feldman
Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works.| Forbes
